Company intelligence / Profile preview

OMERS

Toronto, ON, Canada

Ownership: Private
Employees: ~1000
Development stage: Other

Overview

OMERS is a major Canadian defined benefit pension fund primarily focused on diversified global investments. Through its dedicated Life Sciences division, OMERS actively invests in and acquires royalty interests from biopharmaceutical products and companies, and also supports healthcare infrastructure development. It does not conduct its own drug research and development.

Industry: Investors

Partnerships

Ultragenyx PharmaceuticalXencorVerona PharmaNovaxiaMedical Knowledge GroupAledadeBirdie

Beyond the preview

Go deeper on OMERS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OMERS.

Explore the full profile